Antibody targets and destroys brain clumps and slows memory loss in Alzheimer´s dementia

Very promising results have emerged from a human study in which an antibody called aducanumab  was shown to reduce Aβ-plaques in Alzheimer’s disease, thereby slowing down memory loss. The study, which was published in Nature 2016, used an antibody-immonotherapy to attack and destroy amyloid beta plaques in the brain.

Credit: Sevigny et al, Nature 2016

Credit: Sevigny et al, Nature 2016

In another recently published study, a membrane enriched extract from French blackcurrants showed benefits against formation of amyloid beta plaques as well as.That study was published in the Journal Circulation: Cardiovascular Quality and outcomes.
Previous post

Vegans need Vit B12 supplementation, says the German Nutrition Society

Next post

Elderberry in top 5 most used dietary supplements, ABC report

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *